Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis Yasmin KorzetsAnthony FylesHadar Goldvaser Review 30 March 2019 Pages: 531 - 545
Applying a value-based care framework to post-mastectomy reconstruction Clifford C. SheckterEvan MatrosAnaeze C. Offodile II Review 01 April 2019 Pages: 547 - 551
Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer Jilai TianXiang ChenJiayuh Lin Preclinical study 09 March 2019 Pages: 553 - 566
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion Gen WangSisi QinLiewei Wang Preclinical study 01 April 2019 Pages: 567 - 578
What does risk of future cancer mean to breast cancer patients? Karen KaiserKenzie A. CameronSeema A. Khan Clinical trial 06 March 2019 Pages: 579 - 584
Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia Gaber PlavcIvica RatošaVesna Zadnik Clinical trial 07 March 2019 Pages: 585 - 594
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study F. LynceA. BaracS. M. Swain Clinical trial Open access 09 March 2019 Pages: 595 - 603
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy A. F. de GrootE. J. BlokJ. R. Kroep Clinical trial Open access 13 March 2019 Pages: 605 - 615
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer Peter A. FaschingPaul GassRamona Erber Clinical Trial 13 March 2019 Pages: 617 - 625
Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial Rafael J. A. CámaraLukas SchwentnerInga Bekes Clinical trial 21 March 2019 Pages: 627 - 635
Two-year follow-up of the OptiTrain randomised controlled exercise trial Kate A. BolamSara MijwelYvonne Wengström Clinical trial Open access 26 March 2019 Pages: 637 - 648
Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer Kayla M. DaniellAditya BardiaAlphonse G. Taghian Clinical trial 27 March 2019 Pages: 649 - 658
Efficacy and safety of taxane plus anthracycline with or without cyclophosphamide in Chinese node-positive breast cancer patients: an open-label, randomized controlled trial Yan LinChangjun WangQiang Sun Clinical trial 01 April 2019 Pages: 659 - 666
Progression-free survival (PFS) and toxicities of palbociclib in a geriatric population K. CliftonYi MinM. Karuturi Epidemiology 05 March 2019 Pages: 667 - 674
Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network Elizabeth A. ChrischillesDanielle RileyIngrid M. Lizarraga Epidemiology Open access 09 March 2019 Pages: 675 - 689
Integrating of genomic and transcriptomic profiles for the prognostic assessment of breast cancer Chengxiao YuNa QinYue Jiang Epidemiology 13 March 2019 Pages: 691 - 699
Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project Norbert MarschnerTanja TrarbachThe TMK-Group (Tumour Registry Breast Cancer) Epidemiology Open access 13 March 2019 Pages: 701 - 712
Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study Emil Villiam Holm-RasmussenMaj-Britt JensenTove Filtenborg Tvedskov Epidemiology 14 March 2019 Pages: 713 - 719
Patient-reported symptoms following mastectomy alone or lumpectomy plus radiation for early stage breast cancer: a cohort study Laura E. DavisCourtney FultonClaire M. B. Holloway Epidemiology 16 March 2019 Pages: 721 - 731
Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain Rebeca FontJosep Alfons EspinasJosep M. Borras Epidemiology 18 March 2019 Pages: 733 - 740
Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes Mayu HosioElina UrpilainenPeeter Karihtala Epidemiology Open access 20 March 2019 Pages: 741 - 748
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China Wei CaoYuntao XieTao Ouyang Epidemiology 20 March 2019 Pages: 749 - 754
Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001–2015) Sarah J. AuritSusan S. DevesaCatherine Schairer Epidemiology 26 March 2019 Pages: 755 - 764
Body mass index impacts infection rates in immediate autogenous breast reconstruction Lauren I. WilloughbyJosephine A. D’AbbondanzaMelinda A. Musgrave Epidemiology 01 April 2019 Pages: 765 - 773
Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer Bingnan ZhangElisa F. Long Brief Report 07 March 2019 Pages: 775 - 779
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy Nicholas B. FiguraVictoria T. RizkKamran A. Ahmed Brief Report 11 March 2019 Pages: 781 - 788